Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Long-Term Investments of $8.3 million in Q1 2026, up 2159.4% quarter-over-quarter from $367000.0 in Q4 2025, and up 406.54% on a YoY basis from $1.6 million in Q1 2025.
Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2026) Analysis & Trends
Phibro Animal Health's Long-Term Investments history runs 8 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 406.54% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 406.54% YoY), while the FY2025 annual figure was $89000.0, down 98.28% from the prior year.
- Long-Term Investments was $8.3 million for Q1 2026 at Phibro Animal Health, up from $367000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $8.3 million in Q1 2026 to a low of $89000.0 in Q2 2025.
- Historically, Long-Term Investments has averaged $4.5 million across 5 years, with a median of $5.0 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Long-Term Investments slumped 98.28% in 2025, then jumped 406.54% in 2026.
- A 5-year view of Long-Term Investments shows it stood at $5.1 million in 2022, then fell by 13.33% to $4.4 million in 2023, then increased by 25.24% to $5.5 million in 2024, then plunged by 93.31% to $367000.0 in 2025, then surged by 2159.4% to $8.3 million in 2026.
- The last three Long-Term Investments figures came in at $8.3 million (Q1 2026), $367000.0 (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.90 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 8.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 5.01 Mn |
| Jun 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 5.49 Mn |
| Sep 30, 2024 | 6.40 Mn |
| Jun 30, 2024 | 5.18 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 4.38 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 5.03 Mn |
| Mar 31, 2023 | 5.46 Mn |
| Dec 31, 2022 | 5.06 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | 4.06 Mn |
| Dec 31, 2021 | 4.72 Mn |
| Sep 30, 2021 | 4.76 Mn |
| Jun 30, 2021 | 4.14 Mn |